China-based AK Medical Holdings Ltd (HKG: 1789) has announced that it has received market approval from the National Medical Products Administration (NMPA) for its Acetabular Component of Hip Prosthesis, classified as a Class III medical device. This innovative product is a 3D-printed titanium alloy orthopedic implant.
AK Medical first gained approval for a titanium implant in 2015 and has since focused on enhancing its product offerings. The company utilizes its proprietary 3DACT Bio technology to incorporate bioactive substances, such as calcium and phosphorus, onto the surface of porous titanium alloy implants. This advancement aims to improve the integration of titanium products with bone tissue post-implantation. The newly approved second-generation Acetabular Component features an enhanced bioactive function.- Flcube.com
